We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$6.14B
1-Year Est. Return
42.05%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.1B
AUM Growth
-$211M
(-4.9%)
Cap. Flow
-$383M
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
31.52%
Holding
170
New
36
Increased
33
Reduced
38
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Foods
USFD
|
+$90.4M |
| 2 |
Lumen
LUMN
|
+$84.5M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$80.5M |
| 4 |
Biogen
BIIB
|
+$73.6M |
| 5 |
AET
Aetna Inc
AET
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$99.1M |
| 2 |
CMA
Comerica
CMA
|
+$68M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$64.4M |
| 4 |
CSC
Computer Sciences
CSC
|
+$49.1M |
| 5 |
MetLife
MET
|
+$46.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.84% |
| 2 | Healthcare | 17.85% |
| 3 | Consumer Discretionary | 15.38% |
| 4 | Consumer Staples | 9.47% |
| 5 | Communication Services | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$33.2B
| $193M | 4.71% |
710,500
+278,400
| +64% | +$73.6M |
|
|
TWX
2
DELISTED
Time Warner Inc
TWX
| $188M | 4.58% |
1,869,660
+813,160
| +77% | +$80.5M |
|
3
Constellation Brands
STZ
$22B
| $182M | 4.44% |
939,148
+108,404
| +13% | +$19.3M |
|
4
Regions Financial
RF
$25.9B
| $133M | 3.24% |
9,074,895
+3,506,995
| +63% | +$49.4M |
|
|
5
US Foods
USFD
$22.6B
| $123M | 3% |
4,509,759
+3,176,959
| +238% | +$90.4M |
|
6
Mastercard
MA
$513B
| $101M | 2.47% |
833,585
-189,616
| -19% | -$22.5M |
|
7
Dell
DELL
$334B
| $98.6M | 2.41% |
5,748,077
+1,262,901
| +28% | +$23.1M |
|
8
McDonald's
MCD
$184B
| $95.3M | 2.33% |
622,424
+68,252
| +12% | +$9.86M |
|
9
Burlington
BURL
$16.2B
| $89.1M | 2.18% |
968,713
+456,305
| +89% | +$43.9M |
|
10
PUT
Goldman Sachs
GS
$302B
| $88.8M | 2.17% |
+400,000
| New | +$88.9M |
|
|
11
Lumen
LUMN
$7.13B
| $80.3M | 1.96% |
+3,362,246
| New | +$84.5M |
|
12
Air Products & Chemicals
APD
$67.7B
| $78.6M | 1.92% |
549,600
-18,500
| -3% | -$2.63M |
|
|
ATH
13
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $77.3M | 1.89% |
1,558,329
+330,167
| +27% | +$16.9M |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $77.2M | 1.88% |
+508,263
| New | +$71.8M |
|
|
CLGX
15
DELISTED
Corelogic, Inc.
CLGX
| $76.7M | 1.87% |
1,767,731
-337,878
| -16% | -$14.3M |
|
|
EVHC
16
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $68.6M | 1.67% |
1,094,292
+145,796
| +15% | +$8.4M |
|
17
Comcast
CMCSA
$94.6B
| $68M | 1.66% |
1,747,806
+726,330
| +71% | +$28.6M |
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $65M | 1.59% |
267,467
+34,587
| +15% | +$8.13M |
|
19
Nomad Foods
NOMD
$1.61B
| $63.8M | 1.56% |
4,524,367
-778,641
| -15% | -$9.95M |
|
20
LPL Financial
LPLA
$28.4B
| $62.9M | 1.53% |
1,480,439
+528,780
| +56% | +$21.5M |
|
|
SEE
21
DELISTED
Sealed Air
SEE
| $61.3M | 1.5% |
1,370,500
+352,900
| +35% | +$15.6M |
|
|
SYNH
22
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $59.8M | 1.46% |
1,021,406
+244,457
| +31% | +$12.7M |
|
23
Amazon
AMZN
$2.79T
| $59.5M | 1.45% |
1,229,720
-302,060
| -20% | -$14.4M |
|
24
HDFC Bank
HDB
$120B
| $57.8M | 1.41% |
2,658,000
-786,000
| -23% | -$16.4M |
|
25
KeyCorp
KEY
$23.6B
| $57.1M | 1.39% |
+3,047,557
| New | +$55.1M |
|
Similar funds
MF
LP
SLI
MSU
EQF
PAMP
WCM
MOS
Samlyn Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Samlyn Capital held 170 positions worth $4.1B, down 4.9% from $4.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Samlyn Capital withdrew a net $383M in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Aramark, an estimated $99.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Samlyn Capital opened a new position in Lumen worth $80.3M.
- Samlyn Capital's largest Q2 2017 buy was Lumen: 3,362,246 shares worth $80.3M.
- Samlyn Capital added most to US Foods in Q2 2017, an estimated $90.4M increase.
- Samlyn Capital's biggest Q2 2017 reduction was UnitedHealth, cutting an estimated $42.1M.
- Samlyn Capital fully exited Aramark in Q2 2017, selling an estimated $99.1M.
- Samlyn Capital's ten largest holdings make up 32% of its $4.1B portfolio in Q2 2017.
- Samlyn Capital opened 36 new positions and closed 60 in Q2 2017.
- Samlyn Capital's portfolio value fell 4.9% quarter-over-quarter to $4.1B.
Based on Samlyn Capital's 13F filing for Q2 2017, filed 14 Aug 2017.